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Introduction
The oral mucosal lamina propria (OMLP) harbors a population 
of multipotent and potently immunosuppressive progenitor 
cells (PCs; Davies et al. 2010; Davies et al. 2012). Given the 
well-reported scarless wound-healing ability of the oral 
mucosa, OMLP-PCs represent a readily accessible cell source 
with favorable growth kinetics and potential utility for a vari-
ety of personalized regenerative medicine applications.
In the late 1950s, reprogramming cell fate was achieved via 
nuclear transplantation to redirect cell phenotype (Gurdon 
et al. 1958), and in 2006 Takahashi and Yamanaka built on this 
work. They reported the identification of transcription factors 
that could reprogram adult somatic tissue from mouse dermal 
fibroblasts to an embryonic stem cell–like state. This process 
was termed induced pluripotency.
These induced pluripotent stem cells (iPSCs) were produced 
via viral introduction of 4 transcription factors (OCT4, SOX2, 
KLF4, and cMYC). This work has stimulated research into many 
disparate disease states given the potential use of iPSCs as a per-
sonalized cell source for cellular replacement strategies and to 
provide more accurate disease modeling. This is of particular 
importance for cell types with limited clinical sources (e.g., 
heart; Takahashi and Yamanaka 2006; Takahashi et al. 2007).
Several cell types from the oral cavity have successfully 
been reprogrammed utilizing genome integration of pluripo-
tency genes—including gingival fibroblasts (Eugusa et al. 
2010; Wada et al. 2011), oral mucosal fibroblasts (Miyoshi 
et al. 2010), and stem cells from the dental pulp, apical papil-
lary, and human deciduous teeth (Yan et al. 2010).
Generation of iPSCs through nongenome integrating repro-
gramming strategies is paramount for safer regenerative medi-
cine applications. This has been achieved via a variety of 
approaches, including nonintegrating adenoviral vectors 
(Stadtfeld et al. 2008), delivery of factors via PiggyBac trans-
position (Woltjen et al. 2009), episomal vectors incorporating 
the Epstein-Barr virus OriP and EBNA sequences (Yu et al. 
2009), vectors based on the Sendai virus (Fusaki et al. 2009), 
and direct reprogramming through transient mRNA (Warren et al. 
2010). An approach based on a lentiviral stem cell cassette with 
the cre/loxP system to excise the cassette following reprogram-
ming has been described (Somers et al. 2010) and utilized for the 
reprogramming of apical papilla stem cells (Zou et al. 2012).
Given the accessible nature of OMLP-PCs, their favorable 
growth kinetics, and scarless wound-healing properties of the 
oral mucosa, we sought to determine the feasibility of whether 
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Abstract
Producing induced pluripotent stem cells (iPSCs) from human tissue for use in personalized medicine strategies or therapeutic testing 
is at the forefront of medicine. Therefore, identifying a source of cells to reprogram that is easily accessible via a simple noninvasive 
procedure is of great clinical importance. Reprogramming these cells to iPSCs through nonintegrating methods for genetic manipulation 
is paramount for regenerative purposes. Here, we demonstrate reprogramming of oral mucosal lamina propria progenitor cells 
from patients undergoing routine dental treatment. Reprogramming was performed utilizing nonintegrating plasmids containing all 6 
pluripotency genes (OCT4, SOX2, KLF4, NANOG, LIN28, and cMYC). Resulting iPSCs lacked genetic integration of the vector genes and had 
the ability to differentiate down mesoderm, ectoderm, and endoderm lineages, demonstrating pluripotency. In conclusion, oral mucosal 
lamina propria progenitor cells represent a source of cells that can be obtained with minimal invasion, as they can be taken concurrently 
with routine treatments. The resulting integration-free iPSCs therefore have great potential for use in personalized medicine strategies.
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OMLP-PCs could be reprogrammed through nonintegrating 
plasmid vectors to an induced pluripotent state as a platform 
for future studies assessing the clinically utility of such a cell 
population for regenerative medicine strategies.
Materials and Methods
Cell Culture
Oral cells were isolated from 6-mm biopsies of healthy oral 
(buccal) mucosa from 3 patients at the School of Dentistry, 
Cardiff University, following ethical approval (09/WSE03/18) 
and informed patient consent as previously reported (Stephens 
et al. 1996). OMLP-PCs were then isolated by differential 
adhesion to fibronectin as previously described (Davies et al. 
2010). H9 human embryonic stem cell (hESC) lines from 
WiCell were utilized as positive control and cultured as previ-
ously described (Thomson et al. 1998). Later, established 
OMLP-iPSC colonies were passaged enzymatically with 1 mg/
mL of collagenase and seeded onto fresh tissue culture plates 
prepared with inactivated mouse embryonic fibroblasts 
(iMEFs; Conner 2001) at a density of 1.4 × 104 cells/cm2. 
These cells were obtained from animals sacrificed by a quali-
fied technician under schedule 1 of the UK Animals Scientific 
Procedures Act of 1986. All cells were cultured in a humidified 
incubator at 37 °C and 5% CO
2
.
Nucleofection
Ten-centimeter tissue culture plates were preseeded with 8 × 
105 iMEFs and incubated for 24 h in mouse embryonic fibro-
blast medium: Dulbecco’s Modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum, 2mM L-glutamine, 
100 U/mL of penicillin, 100 μg/mL of streptomycin sulphate, 
and 0.1mM nonessential amino acids (all from Invitrogen). 
Mouse embryonic fibroblast medium was removed and 
replaced with foreskin fibroblast medium—HFF containing MEM 
(Eagle; Invitrogen) supplemented with 10% fetal bovine serum, 
2.0mM GlutaMAX (Invitrogen), 0.1mM β-mercaptoethanol 
(Sigma-Aldrich), 100 U/mL of penicillin, 100 μg/mL of strepto-
mycin sulphate, and 0.1mM nonessential amino acids (Yu et al. 
2009). Then 1 × 106 OMLP-PCs between population doubling 
levels 15 and 20 were pelleted and resuspended in 100 μL of 
nucleofector solution (NHDF-VPD-1001; Lonza). Plasmid 
DNA from 2 plasmids—7.3 μg of pEP4 E02S CK2M EN2L 
containing OCT4, SOX2, NANOG, KLF4, LIN28, and cMYC 
gene inserts and 3.2 μg of pEP4 E02S ET2K containing OCT4, 
SOX2, SV40LT, and KLF4 gene inserts (pEP4 E02S CK2M 
EN2L and pEP4 E02S ET2K were a gift from James Thomson; 
Addgene plasmids 20924 and 20927, respectively)—were 
added, mixed, and nucleofected with program U-20 of the 
Amaxa. Following transfection, cells were immediately seeded 
onto iMEF plates. A transfection control was set up with an 
eGFP plasmid to calculate transfection efficiency. On day 3 
posttransfection, medium was replaced with fresh hESC 
medium consisting of DMEM/F-12 1:1 supplemented with 20% 
knockout serum replacement (Invitrogen), 0.1mM nonessen-
tial amino acids, 1mM L-glutamine, 0.1mM β-mercaptoethanol, 
and 100 ng/mL of basic fibroblast growth factor (bFGF; 
Peprotech). Medium was changed daily and switched to mouse 
embryonic fibroblast–conditioned medium, prepared from 
iMEFs seeded into a 6-well plate at a density of 5 × 104 cells/cm2 
in 2 mL/well of mouse embryonic fibroblast medium. After 
24 h, the feeder layers were washed twice with 2 mL/well of 
phosphate-buffered saline (PBS), and this was replaced with 
2 mL/well of hESC medium without bFGF. Medium was col-
lected and replaced with fresh hESC medium daily from day 8 
posttransfection until cell colonies began to form on days 18 to 
25. Potential iPSC colonies were identified through a live alka-
line phosphatase staining kit (Molecular Probes). Colonies 
were picked, expanded, and characterized as previously 
described (Yu et al. 2009).
Reverse Transcription Polymerase Chain 
Reaction for Pluripotency Markers
Total RNA was extracted from OMLP-PCs, H9, and OMLP-
iPSCs via the traditional Trizol/chloroform method; 0.5 μg of 
RNA was reverse transcribed with M-MLV reverse transcrip-
tase per the manufacturer’s protocol (Promega). A master mix 
of 12 μL of Platinum Blue Super Mix (Invitrogen) was mixed 
with 0.5 μL of 1μM forward and reverse primers specific to the 
gene of interest (βACTIN, OCT4, SOX2, LIN28, KLF4, 
NANOG, and cMYC; sequences and annealing temperatures in 
Appendix Table). One microliter of sample cDNA was added. 
Amplification was performed via the following program: ini-
tial denaturation for 10 min at 95 °C, 40 cycles of 95 °C for 
5 min, 30-s annealing step at the optimal temperature for each 
primer, and elongation at 74 °C for 1 min, finishing with a 
final elongation at 74 °C for 10 min. Products were viewed 
following electrophoresis on standard TAE agarose gels. All 
primer products were sequenced by Central Biotechnology 
Services with a 16-capillary genetic analyzer (3130xl; Applied 
Biosystems).
Polymerase Chain Reaction Analysis of  
Genomic and Episomal DNA
Episomal DNA was extracted from OMLP-iPSCs between 
passages 9 and 14 via a QIAprep Kit, and Genomic DNA was 
extracted with the QIAamp DNA Mini Kit per the manufac-
turer’s instruction (Qiagen). DNA samples were amplified by 
utilizing Taq polymerase per the manufacturer’s protocol 
(Promega). A master mix was combined with 0.5 μL of 1μM 
forward and reverse primer for genes of interest, designed to 
incorporate sections of the plasmid to check for presence of 
plasmid in genomic DNA isolated from OMLP-iPSCs as well 
as endogenous OCT4. Extracted episomal and genomic DNA 
of OMLP-PCs was used as a negative control (sequences and 
annealing temperatures in Appendix Table; Yu et al. 2009).
Quantitative Polymerase Chain Reaction
cDNA from OMLP-PC samples of 3 patients was used to 
establish the level of pluripotency gene expression relative to 
that seen in hESCs (H9). Taqman Gene Expression Assays for 
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OCT4, SOX2, NANOG, KLF4, and cMYC were performed per 
the manufacturer’s protocol (Invitrogen). GAPDH was used as 
a reference gene. A standard curve ensured linear reactions of 
the target genes of interest. H9 cDNA was used as a standard, 
and 10-fold serial dilutions were performed. Each sample was 
assessed in triplicate. Reaction conditions included an initial 
denaturation step at 95 °C for 10 min, followed by 40 cycles, a 
denaturation step at 95 °C for 15 s, then an annealing step at 60 ºC 
for 30 s. The 2-ΔΔCt method was adopted to analyze the relative 
quantities of gene expression (Livak and Schmittgen 2001). 
Statistical analysis was performed via a t test on GraphPad 
InStat software (GraphPad Software, Inc.), and statistical sig-
nificance was assumed when P < 0.05.
Differentiation
Passaged OMLP-iPSC colonies were seeded in 10-cm-diameter 
bacteriological-grade petri dishes in hESC medium without 
bFGF. Cells were refed every second day. Embryoid bodies 
(EBs) developed over a period of 8 d 
before differentiation was initiated. 
Chamber slides were precoated with 
100 μL of Matrigel at a concentration 
of 0.1% (v/v) in hESC medium without 
bFGF for 1 h at 37 ºC / 5% CO
2
. Plates 
were removed from the incubator and 
left at room temperature overnight. 
Three media conditions were used to 
initiate differentiation: 1) hESC 
medium alone, 2) hESC medium sup-
plemented with 10μM retinoic acid 
(diluted in dimethyl sulfoxide; both 
Sigma-Aldrich), and 3) hESC medium 
supplemented with the dimethyl sulf-
oxide diluent as a vehicle control. Stock 
EBs were collected, pelleted, and 
resuspended in each of the 3 media 
conditions before seeding 250 μL onto 
the Matrigel-coated chamber slides. 
Medium was exchanged every other 
day for 14 d.
Immunocytochemistry
OMLP-PCs, H9, OMLP-iPSCs, and 
differentiated OMLP-iPSCs were fixed 
in 4% (v/v) paraformaldehyde for 15 
min at room temperature. Cells were 
permeabilized with 0.1% (v/v) Triton 
X-100 for 20 min. Nonspecific binding 
of the secondary antibody was blocked 
with a solution of 2% (w/v) bovine 
serum albumin (BSA; diluted in PBS) 
for 1 h. Primary antibody—rabbit poly-
clonal antibody against BRACHYURY 
(ab20680, 5 μg/mL), OCT4 (ab19857, 2.8 μg/mL), mouse 
monoclonal antibodies against α-1-FETOPROTEIN (ab3980, 
5 μg/mL), βIII-TUBULIN (ab7751, 2 μg/mL), SOX2 (ab75485, 
1.25 μg/mL), SSEA-4 (ab16287-200, 4.2 μg/mL), TRA-1-60 
(ab15830-100, 4 μg/mL), and TRA-1-81 (ab16289, 4 μg/mL; 
all from Abcam)—and a mouse monoclonal antibody against 
SSEA-5 (2.5 μg/mL; a gift from Dr. Micha Drukker, Stanford 
University) were all diluted in 2% (w/v) BSA in PBS and incu-
bated in contact with the cells at 4 °C overnight. The chamber 
slides were then washed 3 × 5 min with PBS, and the secondary 
antibodies—swine anti-rabbit (F0205, 0.81 g/L) and rabbit anti-
mouse (F0261, 2.3g/L; both Dako)—were diluted 1:50 in 2% 
(w/v) BSA in PBS and incubated in contact with the cells for 1 
h at room temperature. Chamber slides were then washed 3 × 5 
min with PBS before the nuclei were counterstained with 
DAPI-containing (1.5 μg/mL) mounting medium (Vector 
Shield). Appropriate IgG and IgM controls (Santa Cruz 
Biotechnology) were utilized to verify specificity by absence of 
staining.
Figure 1. Characterization of oral mucosal lamina propria progenitor cells (OMLP-PCs) prior 
to reprogramming. (A) Population doubling levels for OMLP-PCs illustrating the point at which 
the cells were reprogrammed (levels 15 to 20). (B) Bipolar morphology of OMLP-PCs prior 
to reprogramming (scale bar = 100 µm). (C) End-point reverse transcription polymerase chain 
reaction (PCR) demonstrating expression of OCT4, SOX2, NANOG, KLF4, and cMYC in OMLP-PCs 
cells. No template controls for reverse transcription (RT-ve) and PCR reaction (H
2
O).  
(D) Quantitative PCR demonstrating expression levels of pluripotency markers relative to H9 cells 
(n = 3; ±SD). *P < 0.05. ***P < 0.001.
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Results
Oral Mucosa Lamina Propria PCs Constitutively 
Express Low Levels of Pluripotency Markers
OMLP-PCs were isolated, cultured, and utilized for reprogram-
ming at a population doubling level of 15 to 20 (Fig. 1A). Cells 
demonstrated a typical fibroblast-like morphology prior to 
reprogramming (Fig. 1B). The pluripotency markers OCT4, 
SOX2, NANOG, KLF4, cMYC, and LIN28 were analyzed, as 
these are the classical iPSC factors utilized to reprogram cells 
back to their pluripotent state (Takahashi et al. 2007; Yu et al. 
2007). H9 hESCs provided a positive control. OMLP-PCs dem-
onstrated expression of all markers with the exception of LIN28 
(Fig. 1C). To quantitate the relative level of expression of these 
genes, quantitative polymerase chain reaction was undertaken. 
H9 hESCs were utilized as the calibrator, as they expressed all 
the pluripotency genes of interest. Compared with hESCs, 
expression of OCT4, SOX2, NANOG, and cMYC was found to 
be significantly (SOX2, P < 0.0001; OCT4 and NANOG, P < 
0.001; cMYC, P < 0.05) lower in OMLP-PCs from 3 patients 
(Fig. 1D). Expression of KLF4 was the only pluripotency gene 
expressed at a significantly higher level in OMLP-PC samples 
when compared with hESCs (KLF4, P < 0.001).
Oral Mucosa Lamina Propria Progenitors Are 
Positive for hESC-Like Markers after Nonviral 
Integrating Reprogramming
The low-level pluripotency gene expression led us to utilize 
plasmids containing all 6 pluripotency genes (OCT4, SOX2, 
NANOG, KLF4, LIN28, and cMYC) to attempt to reprogram the 
OMLP-PCs without the need for viral integration of the 
sequences. Transfection efficiency of the control eGFP plasmid 
in OMLP-PCs was found to be 63.6% (SD, 2.771%; Fig. 2B). 
Live alkaline phosphatase staining confirmed the presence of 
potential iPSC colonies on day 20 (Fig. 2C), as reported for 
iPSCs derived from other cells types (Fusaki et al. 2009; Lu et al. 
2011; Merling et al. 2013). Following nucleofection and culture 
of the OMLP-PCs, putative iPSC colonies were clearly discern-
ible that were similar in appearance to hESCs—namely, with 
tight colony boundaries and cells with a high nuclear:cytoplasmic 
ratio (Fig. 2D).
hESC-like colonies were expanded in culture, first by mechan-
ical means and then by enzymatic passaging. Immunocytochemical 
analysis was then undertaken for typical hESC markers, 
including 2 transcription factors (OCT4 and SOX2) and 4 cell 
surface markers (SSEA-4, SSEA-5, TRA-1-60, and TRA-1-
81). H9 cells were cultured as previously described and used as 
a positive control for the markers (see Appendix Fig.). OMLP-
PCs that had not been nucleofected with the plasmids were 
used as a comparative control to ascertain the presence or 
absence of staining prior to reprogramming (see Appendix 
Fig.). The hESC transcription factors OCT4 and SOX2 and 
cell surface markers SSEA-4, SSEA-5, TRA-1-60, and TRA-
1-81 were found to be present in all (n = 6) OMLP-iPSC-like 
cultures (Fig. 3A–F), suggesting that reprogramming was most 
likely to have occurred. Primary omission control, swine anti-
rabbit secondary omission control, and IgM and IgG (rabbit) 
controls were negative. Importantly, polymerase chain reaction 
confirmed that there was no vector sequence present in the 
genomic DNA (G) isolated from the OMLP-iPSCs after cell 
reprogramming and colony expansion, as demonstrated by 
absence of bands in the iPSC 1G, 14G, and 40G lanes (Fig. 
3G). Residual vector sequence was present in only the epi-
somal DNA (E) isolated from the OMLP-iPSCs, as demon-
strated by presence of bands in iPSC 14E and 40E (Fig. 3G).
Confirmation of Successful Reprogramming 
of OMLP-iPSCs by Differentiation Down 
Mesoderm, Endoderm, and Ectoderm Lineages
To test the reprogrammed oral iPSCs, their differentiation 
potential was investigated. EBs formed readily following 8 d in 
Figure 2. Reprogramming of oral mucosal lamina propria progenitor 
cells (OMLP-PCs). (A) Steps followed for reprogramming of OMLP-
PCs. (B) Phase/GFP image demonstrating transfection of OMLP-PCs 
with eGFP plasmid to establish transfection efficiency. (C) Live alkaline 
phosphatase staining of developing induced pluripotent stem cell 
colonies on day 20. (D) Phase image of an example induced pluripotent 
stem cell colony with tight colony boundary and cells with high 
nuclear:cytoplasmic ratio. Scale bars = 100 µm. bFGF, basic fibroblast 
growth factor; ES, embryonic stem cell medium; HFF, foreskin fibroblast 
medium; MEF, mouse embryonic fibroblast.
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culture without bFGF on non-tissue culture plastic (Fig. 4A). 
To determine whether these EBs cultured from OMLP-iPSCs 
had the potential to form cells from all 3 germ layers, they were 
subjected to 3 distinct differentiation conditions. In all cases, 
EBs derived from each cell type demonstrated flattening out 
and outgrowth of cells from the original EB structure by day 14 
(Fig. 4B). These cultures were stained for typical early stage 
markers of mesoderm, endoderm, and ectoderm. OMLP-PC-iPSCs 
were found to differentiate down early endoderm lineages by dem-
onstrating positive production of α-1-FETOPROTEIN (Fig. 
4C), early ectoderm lineages by the presence of βIII-TUBULIN 
(Fig. 4D), and the early mesoderm lineage by the positive pres-
ence of BRACHYURY (Fig. 4E). All IgG controls and second-
ary omission controls were found to be negative.
Discussion
Reprogramming with Plasmid Vectors
Despite OMLP-PCs expressing pluripotency markers prior to 
reprogramming, we established that, with the exception of 
KLF4, the expression levels of the mark-
ers were at far lower levels than in plu-
ripotent hESCs. OMLP-PCs were, 
however, successfully reprogrammed 
through a non-integrating system con-
sisting of 2 episomal plasmids express-
ing all 6 factors. The fact the KLF4 
expression was elevated compared with 
H9 suggests that the cells may be repro-
grammed following removal of this fac-
tor, further enhancing their potential use 
in clinical applications. Colonies that 
possessed tight boundaries and con-
sisted of cells with very high 
nuclear:cytoplasmic ratio—typical mor-
phologic characteristics of hESCs 
(Thomson et al. 1998)—were identified 
and isolated. These colonies were posi-
tive for the transcription factors OCT4 
and SOX2, which have been reported 
for both iPSCs and hESCs at the RNA 
and protein levels (Bhattacharya et al. 
2005; Lowry et al. 2008; Maherali et al. 
2008; Mali et al. 2008; Li et al. 2009). 
Additionally, the iPSC colonies were 
positive for the stem cell surface mark-
ers SSEA-4, SSEA-5, TRA-1-60, and 
TRA-1-81—markers not detected in 
OMLP-PCs, adding weight to the fact 
that these OMLP-iPSCs had potentially 
been reprogrammed. The presence of 
these typical stem cell markers—
namely, SSEA-4, TRA-1-60, and TRA-
1-81—in the iPSCs is consistent with 
the original research carried out for 
hESCs (Thomson et al. 1998) and results demonstrated for 
iPSCs by several research groups (Maherali et al. 2007; 
Takahashi et al. 2007; Miyoshi et al. 2010) confirming the 
presence of pluripotent stem cells. Moreover, the expression of 
SSEA-5 further confirms that these cells were in an undifferen-
tiated state, given that expression of SSEA-5 is the first of the 
investigated markers known to be lost upon differentiation of 
the stem cells (Tang et al. 2011). When subjected to differentia-
tion conditions, differentiated EBs positively expressed early 
markers of mesoderm (BRACHYURY), endoderm (α-1-
FETOPROTEIN), and ectoderm (βIII-TUBULIN), consistent 
with previous reports for other iPSCs (Aasen et al. 2008; 
Maherali et al. 2008; Mali et al. 2008; Lin et al. 2009).
With respect to oral cell populations and reprogramming, 
fibroblasts from the oral mucosa have already been success-
fully reprogrammed; however, this was carried out with retro-
viral transfer of the genes (Miyoshi et al. 2010), which has 
been linked to formation of carcinomas and poses a clinical 
risk (Okita et al. 2007; Yamanaka 2007; Nakagawa et al. 2008). 
Our work suggests that reprogramming of oral PCs with non-
integrating plasmids for transient expression of the 
Figure 3. Characterization of oral mucosal lamina propria progenitor cells (OMLP-PCs). 
Presence of transcription factors (A) OCT4 in OMLP induced pluripotent stem cell (iPSC) colony. 
(B) SOX2. Presence of stem cell surface markers in OMLP-iPSC colonies (C) SSEA-4, (D) SSEA-5, 
(E) TRA-1-60, and (F) TRA-1-81. (G) Polymerase chain reaction analysis of presence of plasmid in 
E-episomal DNA and G-genomic DNA isolated from 3 OMLP-iPSCs (1, 14, 40) between passages 
9 and 14. Episomal and genomic DNA isolated from OMLP-PCs were used as a negative control. 
Scale bars = 100 µm.
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pluripotency factors is possible and prac-
ticable. To this end, we have confirmed 
that the plasmids did not integrate into 
the genome by identifying the absence of 
transgene sequences in the genomic DNA 
isolated from these iPSC lines via prim-
ers designed to incorporate a small sec-
tions of the plasmid (Fig. 3G). 
Furthermore, our results are consistent 
with those published following the use of 
these 2 plasmids to reprogram human 
dermal fibroblasts. These results demon-
strated iPSC formation without integra-
tion of the plasmid, and only residual 
episomal presence of plasmids was iden-
tified (Yu et al. 2009). The presence of 
endogenous OCT4 in both genomic and 
episomal DNA isolations is an indication 
of genomic DNA contamination of the 
episomal isolation; however, this does 
not significantly detract from the results 
demonstrated by absence of any plasmid 
in the genomic isolations. It is also inter-
esting to speculate that an isolated PC 
population may represent a preferential 
source of cells for use in reprogramming, 
in line with the thoughts of others (Okita 
et al. 2007; Aasen et al. 2008). Indeed, 
studies have suggested that MSC-like 
cells isolated from dental pulp and exfoli-
ated deciduous teeth are reprogrammed 
at a potentially higher efficiency (Yan et 
al. 2010). Hence, we postulate that the resulting iPSCs repre-
sent a potential source of cells that are therefore likely to be 
clinically safer for translational research. Indeed, in relation to 
this clinical translation, much work is currently underway to 
determine chemically defined conditions for the culture of iso-
lated cells, for derivation, and for the onward culture of iPSCs 
to produce those that are ready for regenerative medicine 
applications (Chen et al. 2011; Takeda-Kawaguchi et al. 2014).
Conclusion
The work shows that oral mucosa lamina propria PCs isolated 
from patients undergoing routine dental treatment can be 
reprogrammed to cells demonstrating typical stem cell markers 
and pluripotent characteristics of hESCs through a noninte-
grating system. The resulting iPSCs demonstrated expression 
of early-stage markers of the mesoderm, endoderm, and ecto-
derm, confirming the potential for these cells to differentiate 
into cell types from all 3 germ layers. Future studies will 
address the clinical utility of such cell types for personalized 
regenerative medicine applications.
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